Methods and related materials for detecting differentiation potential of a cell
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for early cancer detection, particularly in colorectal cancer, lack reliable markers to predict the potential of benign polyps to become cancerous, leading to frustrating post-hoc classifications and ineffective screening strategies.
Innovation Solution
A method involving chromatin sensitivity to Micrococcal nuclease (MNase) digestion is used to detect nucleic acid digestion patterns, followed by amplification and qPCR to identify regions susceptible to nuclease digestion, providing a rapid and cost-effective diagnostic assay for cancer potential in polyps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional measures of cell biology (gene expression, DNA methylation, protein modification, metabolite abundance, and histopathology) are used to characterize the current state of a cell, then the cell's current state can be accurately characterized, but the ability to predict future cell capability and differentiation potential is poor
Solution Approach 1:
The patent changes the measurement parameter from traditional cell biology measures (gene expression, protein modification) to chromatin accessibility and nucleosome positioning. This parameter change enables both accurate characterization of current cell state and reliable prediction of future differentiation potential, as chromatin structure reflects the cell's transcriptional program and regulatory state that drive future cell fate decisions
2Reliability
If chromatin sensitivity to MNase digestion is measured, then differentiation potential and cancer risk can be predicted, but the measurement and detection complexity increases
Solution Approach 1:
The patent replaces complex chromatin conformation capture methods (like Hi-C) with a simpler biochemical assay using MNase digestion followed by next-generation sequencing. This substitution maintains the ability to predict differentiation potential while significantly reducing measurement complexity and making the assay more accessible for clinical applications
Solution Approach 2:
The patent extracts and measures specific chromatin features (nucleosome positioning, chromatin accessibility) that are most predictive of differentiation potential, rather than attempting to measure all chromatin properties. This extraction of key features simplifies the measurement while maintaining predictive reliability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the same-day classification of benign polyps as cancer-free or cancer-associated, improving patient outcomes by reducing the risk of undetected cancer development and lowering healthcare costs through early detection and targeted therapies.
Implementation Method 1
exposing a sample comprising nucleosomes to Micrococcal nuclease (MNase) under conditions where MNase can digest nucleic acid, thereby producing digested nucleic acid
Data Source
AI summary
Provided are methods and materials for identifying differentiation potential of a sample comprising nucleosomes, including assays for highly sensitive and specific detection of the pathological potential of cells.